Polychlorinated biphenyl exposure and glucose metabolism in 9-year-old Danish children

Tina K Jensen1, Amalie G Timmermann, Laura I Rossing

  • 1Department of Environmental Medicine (T.K.J., A.G.T., L.I.R., C.D., F.N., P.G.), Department of Sports Science and Clinical Biomechanics (M.R.L., A.G., L.B.A.), Institute of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark; and Department of Biostatistics (O.H.H., T.S.), University of Copenhagen, DK-1165 Copenhagen, Denmark.

Insights

Polychlorinated biphenyls (PCBs) exposure in children was inversely associated with serum insulin levels, not fasting glucose. This suggests PCBs may impact beta-cell function rather than insulin sensitivity.

Area of Science:

  • Environmental Health
  • Pediatric Endocrinology
  • Toxicology

Background:

  • Human exposure to polychlorinated biphenyls (PCBs) is linked to type 2 diabetes in adults.
  • Investigating PCB effects on glucose metabolism in children is crucial for understanding long-term health risks.

Purpose of the Study:

  • To determine the association between plasma PCB concentration and glucose metabolism markers in healthy children.
  • To explore potential links between PCB exposure and insulin resistance or beta-cell function.

Main Methods:

  • A cross-sectional study of 509 healthy Danish children aged 8-10 years.
  • Measured plasma PCB congeners, serum glucose, and insulin.
  • Calculated homeostasis model assessment of insulin resistance (HOMA-IR) and beta-cell function (HOMA-B).

Main Results:

  • PCBs were detected at low concentrations in children's plasma.
  • Higher PCB levels showed a significant inverse association with serum insulin, but not fasting glucose.
  • HOMA-B was inversely affected by increasing PCB exposure, suggesting potential beta-cell toxicity.

Conclusions:

  • PCB exposure in children is strongly associated with lower serum insulin levels.
  • Findings suggest PCBs may impair beta-cell function rather than peripheral insulin sensitivity.
  • Further research is needed to confirm the impact of PCBs on beta-cell function and its long-term consequences.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
12
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K